The importance of perspective in the measurement of quality-adjusted life years

Medical Decision Making

Volumn 17, Issue 1, 1997, Pages 33-41

  Richardson, Jeff ^a   Nord, Erik ^a  

^a FAIRFIELD HOSPITAL   (Australia)

Author keywords

equity; policy; preferences; quality adjusted life years; scaling instruments

Indexed keywords

ARTICLE; HEALTH CARE POLICY; HEALTH CARE UTILIZATION; HEALTH PROGRAM; HUMAN; PATIENT SATISFACTION; QUALITY ADJUSTED LIFE YEAR;

ACTIVITIES OF DAILY LIVING; COST-BENEFIT ANALYSIS; DISABILITY EVALUATION; FOLLOW-UP STUDIES; HEALTH CARE RATIONING; HEALTH POLICY; HEALTH STATUS INDICATORS; HUMANS; QUALITY-ADJUSTED LIFE YEARS;

EID: 0031034403     PISSN: 0272989X     EISSN: None     Source Type: Journal    
DOI: 10.1177/0272989X9701700104     Document Type: Article

References (26)

1. Torrance TW. Measurement of health state utilities for economic appraisal. J Health Econ. 1986;5:1-30.
2. Gescheider GA. Psychophysical scaling. Am Rev Psychol. 1988;39:169-200.
3. Revicki DA, Kaplan RM. Relationship between psychometric and utility based approaches to the measurement of health related quality of life. Quality of Life Res. 1992;2:477-87.
4. Morris J, Durand A. Category rating methods: numerical and verbal scales, Centre for Health Economics, York: Mimo University of York, U.K., 1989.
5. Richardson J. Cost utility analysis: what should be measures? Soc Sci Med. 1994;39:7-21.
6. Nord E. The validity of a visual analogue scale in determining social utility weights for health states. Int J Health Planning Manage. 1992;6:234-42.
7. Broome J. QALYs. J Public Econ. 1993;149-67.
8. Nord E. The QALY: a measure of social value rather than individual utility. Health Econ. 1994;3:89-94.
9. Clark D, Olsen JA. Agency in health care with an endogeneous budget constraint. J Health Econ. 1994;13:231-51.
10. Nord E, Richardson J, Macarounas-Kirchmann K. Social evaluation of health care versus personal evaluation of health states: evidence on the validity of four health state scaling techniques using Norwegian and Australian surveys. Int J Technol Assess Health Care. 1993;9:463-78.
11. Loomes G, McKenzie L. The use of QALYs in health care decision making. Soc Sci Med. 1989;28:299-308.
12. Wagstaff A. QALYs and the equity-efficiency trade-off. J Health Econ. 1991;10:21-41.
13. Nord E. The relevance of health state after treatment in prioritizing between patients. J Med Ethics. 1993;19:37-42.
14. Nord E, Richardson J, et al. Maximizing health benefits versus egalitarianism: an Australian survey of health issues. Soc Sci Med. 1995;41:1429-38.
15. Nord E, Richardson J, Kuhse H, Singer P. Who cares about cost?: Does economic analysis impose or reflect social values. Health Policy. 1995;34:79-94.
16. Nord E, Street A, Richardson J. The significance of age and duration of effect in social evaluation of health care. Health Care Analysis 1996;4:103-11.
17. Harris E. Qualifying the value of life. J Med Ethics. 1987;13: 117-23.
18. Williams A. The measurement of valuation of improvements in health, Newsletter, Centre for Health Economics, York: University of York, U.K., 1988.
19. Lewis PA, Charny M. Which of two individuals do you treat when only their ages are different and you can't treat both? J Med Ethics. 1989;15:28-32.
20. Richardson J. Economic assessment of health care: theory and practice. Australian Econ Rev. 1991;First quarter:2-21.
21. Olsen JA. Persons versus years: two ways of eliciting implicit weights. Health Econ. 1994;3:39-46.
22. Williams A. Ethics and efficiency in the provision of health care. In: Bell JM, Mendus S (eds). Philosophy and Medical Welfare. Cambridge, U.K.: Cambridge University Press, 1987.
23. Nord E. Methods for the quality adjustment of life years. Soc Sci Med. 1992;34:559-69.
24. Nord E. The person-trade-off approach to valuing health care programs. Med Decis Making. 1995;15:201-8.
25. Rawls J. A Theory of Justice. Cambridge, MA: Harvard University Press, 1971.
26. Essink-Bot M-L, Stourthart ME, Bonsel GJ. Generalizability of valuations on health states collected with the EuroQol questionnaire. Health Econ. 1993;2:237-46.